09/30/2026
In honor of , we're taking over the social media accounts for the United Leukodystrophy Foundation today. Follow along with them to learn more about cureCADASIL.
đź’™ Meet cureCADASIL
cureCADASIL is a volunteer-led nonprofit dedicated to advancing research, awareness, and support by connecting patients, researchers, clinicians, and partner organizations to accelerate CADASIL research and therapeutic development.
CADASIL is the most common inherited form of stroke, caused by a change in the NOTCH3 gene. The disease damages the brain's small blood vessels and can lead to migraines, recurrent strokes, seizures, cognitive decline, and, for some, dementia. Many individuals also experience serious psychiatric symptoms, including depression, apathy, and behavioral changes.
Symptoms often begin between ages 30 and 50, yet CADASIL is frequently overlooked, misdiagnosed, or diagnosed late. CADASIL affects people differently, has no approved treatments and offers few effective symptomatic options.
Because CADASIL is hereditary, each child of an affected parent has a 50% chance of inheriting the disease, making its impact deeply personal for families across generations.
Through research, education, advocacy, and community support, cureCADASIL is working toward a future with better treatments and ultimately a cure.
Follow along today to learn more about our mission and the impact we are making for the CADASIL community.